Literature DB >> 32341068

Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Jasper A Heinsbroek1, Taco J De Vries2,3, Jamie Peters1.   

Abstract

Glutamate is the main excitatory neurotransmitter in the brain and is of critical importance for the synaptic and circuit mechanisms that underlie opioid addiction. Opioid memories formed over the course of repeated drug use and withdrawal can become powerful stimuli that trigger craving and relapse, and glutamatergic neurotransmission is essential for the formation and maintenance of these memories. In this review, we discuss the mechanisms by which glutamate, dopamine, and opioid signaling interact to mediate the primary rewarding effects of opioids, and cover the glutamatergic systems and circuits that mediate the expression, extinction, and reinstatement of opioid seeking over the course of opioid addiction.
Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32341068      PMCID: PMC7718856          DOI: 10.1101/cshperspect.a039602

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  265 in total

1.  An inhibitory interface gates impulse traffic between the input and output stations of the amygdala.

Authors:  S Royer; M Martina; D Paré
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Blockade of mGluR5 in the nucleus accumbens shell but not core attenuates heroin seeking behavior in rats.

Authors:  Zhong-ze Lou; Ling-hong Chen; Hui-feng Liu; Lie-min Ruan; Wen-hua Zhou
Journal:  Acta Pharmacol Sin       Date:  2014-11-17       Impact factor: 6.150

3.  Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.

Authors:  Yoichi Kawasaki; Chunyu Jin; Katsuya Suemaru; Hiromu Kawasaki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita; Hiroaki Araki
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats.

Authors:  Kris Rutten; Elizabeth L Van Der Kam; Jean De Vry; Walter Bruckmann; Thomas M Tzschentke
Journal:  Addict Biol       Date:  2011-01       Impact factor: 4.280

5.  Heroin relapse requires long-term potentiation-like plasticity mediated by NMDA2b-containing receptors.

Authors:  Haowei Shen; Khaled Moussawi; Wenhua Zhou; Shigenobu Toda; Peter W Kalivas
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

6.  Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin.

Authors:  S R Sesack; A Y Deutch; R H Roth; B S Bunney
Journal:  J Comp Neurol       Date:  1989-12-08       Impact factor: 3.215

7.  Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole.

Authors:  T M Tzschentke; W J Schmidt
Journal:  Neurosci Lett       Date:  1998-02-13       Impact factor: 3.046

8.  Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala.

Authors:  Yuan-Yuan Hou; You-Qing Cai; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

9.  Neurophysiology of converging synaptic inputs from the rat prefrontal cortex, amygdala, midline thalamus, and hippocampal formation onto single neurons of the caudate/putamen and nucleus accumbens.

Authors:  D M Finch
Journal:  Hippocampus       Date:  1996       Impact factor: 3.899

10.  Reduction of the Morphine Maintenance by Blockade of the NMDA Receptors during Extinction Period in Conditioned Place Preference Paradigm of Rats.

Authors:  Ali Siahposht-Khachaki; Zahra Fatahi; Abbas Haghparast
Journal:  Basic Clin Neurosci       Date:  2016-10
View more
  4 in total

1.  Alterations in Excitatory and Inhibitory Synaptic Development Within the Mesolimbic Dopamine Pathway in a Mouse Model of Prenatal Drug Exposure.

Authors:  Taylor Boggess; James C Williamson; Ethan B Niebergall; Hannah Sexton; Anna Mazur; Richard D Egleton; Lawrence M Grover; W Christopher Risher
Journal:  Front Pediatr       Date:  2021-12-13       Impact factor: 3.418

2.  The distinct roles of various neurotransmitters in modulating methamphetamine-induced conditioned place preference in relevant brain regions in mice.

Authors:  Hongliang Su; Junmei Bai; Yao Fan; Tingting Sun; Yan Du; Yanhua Li; Zhiwen Wei; Teng Chen; Xiangjie Guo; Keming Yun
Journal:  Neuroreport       Date:  2022-02-02       Impact factor: 1.837

Review 3.  The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.

Authors:  Richard C J Bradlow; Michael Berk; Peter W Kalivas; Sudie E Back; Richard A Kanaan
Journal:  CNS Drugs       Date:  2022-03-22       Impact factor: 6.497

Review 4.  Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.

Authors:  Francisco Navarrete; María Salud García-Gutiérrez; Ani Gasparyan; Amaya Austrich-Olivares; Jorge Manzanares
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.